Signal peptide peptidase-like 2b (SPPL2b) is an intramembrane protease enriched in the brain that has been implicated in synaptic function, immune signaling, and neuronal development. Despite these associations, its physiological role in maintaining brain and neuronal homeostasis, particularly across the lifespan, remained poorly defined. The study summarized here set out to characterize the consequences of constitutive Sppl2b deletion on the brain proteome and neuronal function, with attention to how those consequences evolve with aging.
Investigators compared wild-type and SPPL2b-deficient mice at two adult ages: 3 months and 12 months. They applied quantitative shotgun proteomics to cortex and hippocampus samples to identify proteome-wide changes associated with SPPL2b loss and aging. Key follow-up and validation approaches included western blot and immunofluorescence to confirm proteomic findings, morphological analysis of dendritic spines, and behavioral testing to assess functional consequences.
Quantitative proteomics revealed that constitutive deletion of Sppl2b produced alterations in biological processes relevant to neuronal function. The changes were notable in pathways related to intracellular transport and synaptic components. The source reports that these proteomic shifts were observed in both cortex and hippocampus and that the pattern of changes differed from the normal age-associated proteomic remodeling seen in wild-type animals.
Among the altered proteins, the study highlighted consistent upregulation of the kinesin motor protein KIF1A and the synaptic vesicle protein VAMP2 in SPPL2b-deficient brain tissue. These proteins are directly connected to axonal transport and synaptic vesicle trafficking, processes essential for presynaptic function, vesicle delivery, and synaptic maintenance. The upregulation suggests that SPPL2b deficiency affects the abundance of proteins that regulate trafficking of synaptic components.
The authors report that SPPL2b deletion attenuated normal age-associated changes in synaptic pathways. In other words, the expected proteomic remodeling of synaptic proteins that accompanies aging was reduced when SPPL2b was absent. This observation links SPPL2b to the trajectory of synaptic proteostasis over time and indicates that SPPL2b-dependent mechanisms contribute to how the synaptic proteome adapts during brain aging.
Morphological analyses demonstrated increased dendritic spine density in SPPL2b-deficient mice. In addition to spine density changes, the study reported morphological remodeling of pyramidal neurons, consistent with alterations in synaptic structure and potentially synaptic connectivity. These structural changes provide a cellular correlate to the proteomic shifts in synaptic and transport proteins.
Behavioral testing revealed that SPPL2b-deficient mice exhibited increased locomotor activity and reduced anxiety-like behavior compared with controls. These functional outcomes align with the observed synaptic and neuronal structural changes, suggesting that SPPL2b influences behavior through effects on synaptic proteostasis and neuronal architecture.
The study combined discovery proteomics with targeted validation by western blot and immunofluorescence, plus dendritic spine quantification and behavioral assays, to link molecular, cellular, and functional phenotypes. The source text does not provide detailed numerical results, statistical values, or mechanistic dissection beyond these associations. Where precise quantitative metrics, effect sizes, or experimental replicates would further clarify the findings, those details were not reported in the source.
Findings identify a previously unrecognized association between SPPL2b and remodeling of the synaptic proteome during aging. The consistent upregulation of trafficking-related proteins such as KIF1A and VAMP2, along with structural and behavioral alterations, nominate SPPL2b-dependent pathways as candidates for further mechanistic and functional investigation. The study suggests these pathways could be relevant to understanding synaptic changes in brain aging and may warrant exploration in models of neurodegenerative disease.
Summary
Constitutive loss of SPPL2b in mice is associated with proteomic shifts in axonal transport and synaptic vesicle trafficking proteins, attenuation of age-associated synaptic proteome remodeling, increased dendritic spine density and pyramidal neuron remodeling, and behavioral changes including increased locomotion and reduced anxiety-like behavior. The reported results link SPPL2b to synaptic proteostasis during aging and recommend SPPL2b-related mechanisms for additional study; however, detailed quantitative data and mechanistic causality were not provided in the source article.